Literature DB >> 23143347

Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design.

Sudha R Raman1, Stephen W Marshall, Kevin Haynes, Bradley N Gaynes, Albert Jackson Naftel, Til Stürmer.   

Abstract

OBJECTIVE: The aim of the present work was to assess the short-term effects of stimulant medication use on risk of injury among children diagnosed as having attention deficit hyperactivity disorder (ADHD).
METHODS: The study group for this self-controlled case series study was children aged 1-18 years old diagnosed as having ADHD who experienced an incident medically-attended injury event and received at least one prescription for stimulant medication between 1993 and 2008 (n=328), identified from The Health Improvement Network primary care database from the UK. Conditional Poisson regression was used to estimate incident rate ratios (IRR) and 95% CIs for injury comparing periods of time exposed to stimulant medication to unexposed periods.
RESULTS: Among children with ADHD prescribed stimulant medication, the rate of medically-attended injury was decreased during periods of stimulant medication use as compared to unexposed periods (IRR 0.68, 95% CI 0.50 to 0.91). There was evidence of a protective association among males and among children aged 10-14 years. This effect did not change over time on treatment.
CONCLUSIONS: Stimulant medication use may decrease the risk of injury among children treated for ADHD, although unmeasured time varying confounding may be an alternative explanation. Injury risk may be considered during the decision-making process with regard to medication continuation among children with ADHD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143347     DOI: 10.1136/injuryprev-2012-040483

Source DB:  PubMed          Journal:  Inj Prev        ISSN: 1353-8047            Impact factor:   2.399


  12 in total

1.  Do we face the same dilemma on pediatric psychopharmacology in low and middle income countries?

Authors:  Luis Augusto Rohde
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

Review 2.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

Authors:  Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

3.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors:  Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

4.  Effectiveness of Pharmacological Treatment for Attention-Deficit/Hyperactivity Disorder on Physical Injuries: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Kenneth K C Man; Patrick Ip; Esther W Chan; Siew-Ling Law; Miriam T Y Leung; Evelyn X Y Ma; Wan-Ting Quek; Ian C K Wong
Journal:  CNS Drugs       Date:  2017-12       Impact factor: 5.749

5.  ADHD Medication and Substance-Related Problems.

Authors:  Patrick D Quinn; Zheng Chang; Kwan Hur; Robert D Gibbons; Benjamin B Lahey; Martin E Rickert; Arvid Sjölander; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  Am J Psychiatry       Date:  2017-06-29       Impact factor: 18.112

6.  Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents.

Authors:  Laura Ghirardi; Henrik Larsson; Zheng Chang; Qi Chen; Patrick D Quinn; Kwan Hur; Robert D Gibbons; Brian M D'Onofrio
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-07-11       Impact factor: 8.829

7.  Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan.

Authors:  Yin-To Liao; Yao-Hsu Yang; Ting-Yu Kuo; Hsin-Yi Liang; Kuo-You Huang; Tsu-Nai Wang; Yena Lee; Roger S McIntyre; Vincent Chin-Hung Chen
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-08-30       Impact factor: 4.785

8.  Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders.

Authors:  Laura Ghirardi; Qi Chen; Zheng Chang; Ralf Kuja-Halkola; Charlotte Skoglund; Patrick D Quinn; Brian M D'Onofrio; Henrik Larsson
Journal:  J Child Psychol Psychiatry       Date:  2019-10-18       Impact factor: 8.982

9.  Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: protocol for a systematic review and meta-analysis.

Authors:  Maite Ruiz-Goikoetxea; Samuele Cortese; Maite Aznarez-Sanado; Sara Magallon; Elkin O Luis; Noelia Álvarez Zallo; Pilar de Castro-Manglano; Cesar Soutullo; Gonzalo Arrondo
Journal:  BMJ Open       Date:  2017-09-25       Impact factor: 2.692

10.  The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study.

Authors:  Christina Lindemann; Ingo Langner; Tobias Banaschewski; Edeltraut Garbe; Rafael T Mikolajczyk
Journal:  Front Pediatr       Date:  2017-10-24       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.